Quantitative structure–activity relationship studies on acetylcholinesterase enzyme inhibitory effects of Amaryllidaceae alkaloids
暂无分享,去创建一个
Sarel F. Malan | G. Stafford | J. Staden | S. Malan | J. Van Staden | E. E. Elgorashi | Gary I. Stafford | E. Elgorashi
[1] Gordon M. Crippen,et al. Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions , 1987, J. Chem. Inf. Comput. Sci..
[2] J. Staden,et al. Alkaloids from Crinum bulbispermum , 1999 .
[3] Arup K. Ghose,et al. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics , 1989, J. Chem. Inf. Comput. Sci..
[4] Gareth Thomas,et al. Medicinal Chemistry: An Introduction , 2000 .
[5] Sarel F Malan,et al. Physicochemical prediction of a brain-blood distribution profile in polycyclic amines. , 2003, Bioorganic & medicinal chemistry.
[6] J. van Staden,et al. Alkaloids from Crinum macowanii. , 2001, Biochemical systematics and ecology.
[7] A. Mutlib,et al. Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. , 1996, The Journal of pharmacology and experimental therapeutics.
[8] C. Codina,et al. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. , 2002, Life sciences.
[9] H. Barz,et al. Inhibition of Acetylcholinesterase Activity in Human Brain Tissue and Erythrocytes by Galanthamine, Physostigmine and Tacrine , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[10] J. Coyle,et al. Galanthamine, an acetylcholinesterase inhibitor: A time course of the effects on performance and neurochemical parameters in mice , 1989, Pharmacology Biochemistry and Behavior.
[11] S Nagashima,et al. Purification and characterization of UDP-glucuronate: baicalein 7-O-glucuronosyltransferase from Scutellaria baicalensis Georgi. cell suspension cultures. , 2000, Phytochemistry.
[12] E. Giacobini,et al. Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspects , 1988 .
[13] N. Cutler,et al. Review of the acetylcholinesterase inhibitor galanthamine , 2000, Expert opinion on investigational drugs.
[14] J. Staden,et al. Alkaloids from Cyrtanthus falcatus , 2003 .
[15] J L Sussman,et al. Structure of acetylcholinesterase complexed with (−)‐galanthamine at 2.3 Å resolution , 1999, FEBS letters.
[16] J. van Staden,et al. Alkaloids from Crinum moorei. , 2001, Phytochemistry.
[17] J. van Staden,et al. Acetylcholinesterase Enzyme Inhibitory Effects of Amaryllidaceae Alkaloids , 2004, Planta medica.